Patient Recruitment Begins for Phase 1 Trial of P-BCMA-101 CAR T-Cell Therapy for Multiple Myeloma – Myeloma Research News
Myeloma Research News |
Patient Recruitment Begins for Phase 1 Trial of P-BCMA-101 CAR T-Cell Therapy for Multiple Myeloma
Myeloma Research News A Phase 1 trial sponsored by Poseida Therapeutics for the company's investigational CAR T-cell therapy for multiple myeloma, P-BCMA-101, is now enrolling participants. The potential therapy specifically targets a molecule found on the surface of … |
